N🟁N

Bronstein, Gewirtz amp;; Grossman, LLC Announces Investigation of Ebix, Inc.

  //science-technology.news-articles.net/content/2 .. man-llc-announces-investigation-of-ebix-inc.html
  Published in Science and Technology on Monday, February 25th 2013 at 5:45 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ebix, Inc. -- NEW YORK, Feb. 25, 2013 /PRNewswire/ --

NEW YORK, Feb. 25, 2013 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Ebix, Inc. ("Ebix" or the "Company") (NASDAQ: [ EBIX ]), concerning whether the company has violated federal securities laws.

On February 21, 2013 shares of Ebix fell $5.07, or 27 percent, to close at $14 after a report posted on the website Seeking Alpha by Gotham City Research LLC alleged that the Company hid a $65.8 million related-party loan to its Singapore subsidiary from U.S. regulators.  The report said the loan appeared in a disclosure form filed by Atlanta-based Ebix's Singapore unit and was never disclosed in the company's U.S. filings.  The related-party loan originated in 2009. 

If you are aware of any facts relating to this investigation, or purchased shares of Ebix, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [ eitan@bgandg.com ]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: 
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
[ eitan@bgandg.com ]

SOURCE Bronstein, Gewirtz & Grossman, LLC